HCA Healthcare Officer Files Form 144 to Sell $16.3M in Common Stock
HCA Healthcare, Inc.
Subscribe to track HCA
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
📋 Form 144 Filing: HCA Healthcare, Inc. ($HCA) Insider: Jon M Foster (Officer) Proposed Transaction: Sale of 31,742 shares of Common Stock Aggregate Value: $16,317,602.99 (~$514.07/share) Broker: Merrill Lynch Approximate Sale Date: 2026-11-04 Significance: High
Comprehensive Analysis
Executive Summary
On November 4, 2026, Jon M Foster, an Officer of HCA Healthcare, Inc. ($HCA), submitted a Form 144 notice disclosing the intent to sell up to 31,742 shares of common stock with an aggregate market value of approximately $16.32 million through Merrill Lynch.
Transaction Breakdown
The proposed sale comprises shares acquired through stock award exercises and vestings:
- 13,254 shares: Acquired on February 5, 2026 via stock award exercise.
- 2,888 shares: Acquired on February 10, 2026 via vesting of a stock award.
- 15,600 shares: Acquired on November 4, 2026 via stock award exercise.
Context & Significance
- Total Consideration: $16,317,602.99 at an estimated price of $514.07 per share.
- Market Impact: The planned sale represents approximately 0.015% of HCA's 208,892,500 total shares outstanding.
- Significance Level: High, driven by the substantial dollar value ($16.3M+) of the proposed executive liquidation.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.